At Hanabusa IVF, “research” isn’t a separate department—it’s the mindset behind how we refine protocols, evaluate lab performance, and continuously improve patient care. We focus on practical, outcomes-driven innovation in stimulation strategy, embryo development, and cryopreservation—especially for patients who need a more customized approach (“One Size Doesn’t Fit All”).
We translate published science and real-world embryology data into clinical decisions that protect egg competence, embryo potential, and patient safety—without defaulting to higher medication or one-size protocols.
Hanabusa IVF received Kitazato’s Best Practice in Vitrification Recognition (2025)—an international recognition program that highlights outstanding cryopreservation programs and clinical results among Cryotop® Method users.
We treat lab performance and protocol design as systems that can be measured, refined, and validated—so patients benefit from consistency and precision.
We value collaboration with leaders in reproductive medicine and embryology, and we support ongoing learning to keep our lab and clinical teams aligned with evolving best practices—especially in vitrification and embryo handling.
.png)
A peer-reviewed publication relevant to cryopreservation technique and validation: “Ultra-fast vitrification and rapid elution of human oocytes: Part II – verification of blastocyst development from mature oocytes” (Reproductive BioMedicine Online, 2024).
.png)
.png)
.png)
.jpg)
.jpg)
